Skip to main content

Table 3 Results of the GEE models

From: Effectiveness of a brief hope intervention for chronic kidney disease patients on the decisional conflict and quality of life: a pilot randomized controlled trial

Variables

 

Adjusted Model#

β

SE

95% CI

Wald χ2

P

State Hope Scale—Total

Time

0.659

0.757

[-0.824, 2.143]

0.759

0.384

Group

-1.383

2.715

[-6.703, 3.937]

0.260

0.610

Group*Time

1.690

0.976

[-0.222, 3.603]

3.001

0.083

Decisional Conflict Scale—Total

Time

-16.911

1.419

[-19.692, -14.131]

142.126

 < 0.001*

Group

-10.551

5.629

[-21.584, 0.482]

3.513

0.061

Group*Time

5.519

1.965

[1.667, 9.370]

7.885

0.005*

Decisional Conflict Scale—Being informed

Time

-24.705

2.731

[-30.057, -19.354]

81.863

 < 0.001*

Group

-16.551

9.735

[-35.632, 2.530]

2.890

0.089

Group*Time

9.724

3.660

[2.550, 16.898]

7.058

0.008*

Decisional Conflict Scale—Values clarity

Time

-25.039

3.143

[-31.200, -18.878]

63.452

0.000*

Group

-26.314

9.898

[-45.713, -6.915]

7.068

0.008*

Group*Time

14.237

4.072

[6.256, 22.218]

12.225

 < 0.001*

KDQOL-36 Subscales

KDQOL-36—SF12

KDQOL-36 (PCS)a

Time

1.873

2.041

[-2.127, 5.874]

0.843

0.359

Group

-4.677

7.828

[-20.020, 10.666]

0.357

0.550

Group*Time

3.590

3.328

[-2.934, 10.113]

1.163

0.281

KDQOL-36 (MCS)b

Time

-0.155

1.549

[-2.882, 3.192]

0.010

0.920

Group

-12.575

7.096

[-26.483, 1.333]

3.140

0.076

Group*Time

6.093

2.343

[1.501, 6.763]

6.763

0.009*

KDQOL-36—Effects of kidney disease

Time

-1.470

1.201

[-3.823, 0.883]

1.499

0.221

Group

-7.111

4.148

[-15.241, 1.020]

2.938

0.087

Group*Time

4.475

1.551

[1.435, 7.516]

8.324

0.004*

  1. KDQOL Kidney Disease Quality of Life Questionnaire, aPhysical Component Summary; bMental Component Summary
  2. #Age and sex adjusted; SE standard error, CI confidence interval
  3. *p < 0.05
  4. Only total scores and significant subscales scores of the respective scale are stated in this table. Full set of GEE results can be found in the supplementary table 1